An A to Z Guide on Comparator Sourcing
Without a comparator drug, a clinical trial will fail. Without proper guidance, the individuals responsible for sourcing these drugs can be prevented from achieving their KPI’s. These can be in the form of budget overspending, purchasing counterfeit products or inadequate supply of the requested drug. Often, this results in trial termination, which could mean a patient being denied a therapy that could potentially improve their lives. The key facts are that comparator procurement is a complex and dynamic process that requires foresight which can only be developed from experience.
Khaled El-Gendy, our Vice President, wishes to teach you how to deal with the key issues you and your company could potentially face in your upcoming or current clinical trial. Khaled has worked globally as both a supplier of clinical trial comparator products as well as a customer. In this presentation, you will learn about the commercial trends in this sector, GxP landscapes and the micro-economical considerations for a patient-centric clinical trial.
Some of the topics that will be covered include, A) The pros and cons of central sourcing, B) Planning a phase dependent sourcing strategy with recommendations on direct and open-market sourcing and C) Supplier quality management and due diligence techniques.
Pilatus Clinical Services are a global specialist in comparator sourcing, with a team solely dedicated to simplifying your drug procurement. Over decades of working in this industry, we have built a trusted network of suppliers and with it, developed smarter methods of sourcing comparator products. This webinar gives you the opportunity to pick the brains of one of our more senior representatives and acquire knowledge that can help you succeed in all your current and forthcoming clinical trial projects.
Presented by
Khaled El-Gendy,
Vice President
Khaled has over 20 years of pharmaceutical industry experience. Prior to Pilatus, he was Head of Commercial Operations for Fisher Clinical Services and before that, led the Global Sales of Clinical Trial Supplies team at Roche. Khaled will be coming from the EU and his experiences as both a supplier of clinical trial comparator products as well as a customer will no doubt bring valuable insight to all who attend.
Kevin Wolfe,
Director
Kevin is one of the three directors at Pilatus. He has an additional function as the Responsible Person (RP) for quality assurance and regulatory compliance. Kevin has a solutions-oriented approach that draws on more than 30 years’ experience in both the clinical services and pharmaceutical sectors. Many of his roles have encompassed business strategy development and change management; such as the integration and subsequent relocation of the Glaxo and Wellcome groups.
